Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study

PROMISE Investigators; Eero  Poukka; Caren van Roekel; Topi Turunen; Ulrike Baum; Rolf Kramer; Elizabeth  Begier; Lance Presser; Anne C. Teirlinck; Terho Heikkinen; Mirjam J. Knol; Hanna Nohynek

doi:10.1093/infdis/jiad484

Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study

PROMISE Investigators, Eero Poukka, Caren van Roekel, Topi Turunen , Ulrike Baum, Rolf Kramer, Elizabeth Begier, Lance Presser, Anne C. Teirlinck , Terho Heikkinen, Mirjam J. Knol , Hanna Nohynek

Research output: Contribution to journal › Article › peer-review

Abstract

Currently several immunisation products are being developed against respiratory syncytial virus (RSV) for children, pregnant females and older adults, and some products have already received authorisation. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct post-marketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunisation product effectiveness against RSV-specific and non-specific outcomes. To conduct a study on the basis of this generic protocol the researchers can use any relevant databases or healthcare registers that are available at the study site.

Original language	English
Pages (from-to)	s84-s91
Number of pages	18
Journal	The Journal of Infectious Diseases
Volume	229
Issue number	Supplement 1
DOIs	https://doi.org/10.1093/infdis/jiad484
Publication status	Published - 1 Nov 2023

Keywords / Materials (for Non-textual outputs)

Respiratory syncytial
vaccine
monoclonal antibody
maternal immunization

Access to Document

10.1093/infdis/jiad484Licence: All Rights Reserved

Effectiveness_of_vaccines_and_monoclonal_antibodies_against_respiratory_syncytial_virus_Generic_protocol_for_register-based_cohort_studyLicence: Creative Commons: Attribution (CC-BY)

Cite this

PROMISE Investigators, Poukka, E., van Roekel, C., Turunen , T., Baum, U., Kramer, R., Begier, E., Presser, L., Teirlinck , A. C., Heikkinen, T., Knol , M. J., & Nohynek , H. (2023). Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study. The Journal of Infectious Diseases, 229(Supplement 1), s84-s91. https://doi.org/10.1093/infdis/jiad484

@article{dbcf4169e78c4d89aa52d6688d4c44ae,

title = "Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study",

abstract = "Currently several immunisation products are being developed against respiratory syncytial virus (RSV) for children, pregnant females and older adults, and some products have already received authorisation. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct post-marketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunisation product effectiveness against RSV-specific and non-specific outcomes. To conduct a study on the basis of this generic protocol the researchers can use any relevant databases or healthcare registers that are available at the study site.",

keywords = "Respiratory syncytial, vaccine, monoclonal antibody, maternal immunization",

author = "\{PROMISE Investigators\} and Harish Nair and Eero Poukka and \{van Roekel\}, Caren and Topi Turunen and Ulrike Baum and Rolf Kramer and Elizabeth Begier and Lance Presser and Teirlinck, \{Anne C.\} and Terho Heikkinen and Knol, \{Mirjam J.\} and Hanna Nohynek",

year = "2023",

month = nov,

day = "1",

doi = "10.1093/infdis/jiad484",

language = "English",

volume = "229",

pages = "s84--s91",

journal = "The Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "Supplement 1",

}

PROMISE Investigators, Poukka, E, van Roekel, C, Turunen , T, Baum, U, Kramer, R, Begier, E, Presser, L, Teirlinck , AC, Heikkinen, T, Knol , MJ & Nohynek , H 2023, 'Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study', The Journal of Infectious Diseases, vol. 229, no. Supplement 1, pp. s84-s91. https://doi.org/10.1093/infdis/jiad484

TY - JOUR

T1 - Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study

AU - PROMISE Investigators

AU - Nair, Harish

AU - Poukka, Eero

AU - van Roekel, Caren

AU - Turunen , Topi

AU - Baum, Ulrike

AU - Kramer, Rolf

AU - Begier, Elizabeth

AU - Presser, Lance

AU - Teirlinck , Anne C.

AU - Heikkinen, Terho

AU - Knol , Mirjam J.

AU - Nohynek , Hanna

PY - 2023/11/1

Y1 - 2023/11/1

N2 - Currently several immunisation products are being developed against respiratory syncytial virus (RSV) for children, pregnant females and older adults, and some products have already received authorisation. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct post-marketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunisation product effectiveness against RSV-specific and non-specific outcomes. To conduct a study on the basis of this generic protocol the researchers can use any relevant databases or healthcare registers that are available at the study site.

AB - Currently several immunisation products are being developed against respiratory syncytial virus (RSV) for children, pregnant females and older adults, and some products have already received authorisation. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct post-marketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunisation product effectiveness against RSV-specific and non-specific outcomes. To conduct a study on the basis of this generic protocol the researchers can use any relevant databases or healthcare registers that are available at the study site.

KW - Respiratory syncytial

KW - vaccine

KW - monoclonal antibody

KW - maternal immunization

U2 - 10.1093/infdis/jiad484

DO - 10.1093/infdis/jiad484

M3 - Article

SN - 0022-1899

VL - 229

SP - s84-s91

JO - The Journal of Infectious Diseases

JF - The Journal of Infectious Diseases

IS - Supplement 1

ER -

Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this